StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report report published on Thursday. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Athersys Price Performance
Shares of ATHX opened at $0.01 on Thursday. Athersys has a 52 week low of $0.01 and a 52 week high of $1.99. The stock has a market capitalization of $833,206.50, a price-to-earnings ratio of -0.01 and a beta of -0.90.
About Athersys
Further Reading
- Five stocks we like better than Athersys
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Canada Bond Market Holiday: How to Invest and Trade
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
